Elizabeth Trentacost focuses her practice on a broad range of FDA regulatory matters involving pharmaceutical and medical device manufacturers. She spent several years as a Regulatory Counsel in the Office of Regulatory Policy in FDA's Center for Drug Evaluation and Research. At FDA, she was involved in a wide variety of policy issues involving drug approvals, responded to citizen petitions, developed guidance for industry, and counseled on matters relating to Hatch-Waxman marketing exclusivities.
Prior to joining FDA, Ms. Trentacost worked at a law firm in Washington, DC where she focused on international trade investigations and appellate litigation.
- JD, Georgetown University Law Center, 2012
- BA, Political Science, Emory University, 2007
- District of Columbia
- Regulatory Counsel, US Food & Drug Administration